288 related articles for article (PubMed ID: 31918623)
21. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
[TBL] [Abstract][Full Text] [Related]
22. Frequency of Consuming Breakfast Meals and After-Dinner Snacks Is not Associated with Postmenopausal Breast Cancer Risk: Women's Health Initiative Observational Study.
Elahy V; Thomson C; Neuhouser ML; Jiang L; Lee S; Pan K; Vitolins M; Chlebowski R; Lane D; Odegaard AO
J Nutr; 2023 Apr; 153(4):1089-1100. PubMed ID: 36828152
[TBL] [Abstract][Full Text] [Related]
23. Association between selenium intake and breast cancer risk: results from the Women's Health Initiative.
Guo D; Hendryx M; Liang X; Manson JE; He K; Vitolins MZ; Li Y; Luo J
Breast Cancer Res Treat; 2020 Aug; 183(1):217-226. PubMed ID: 32607639
[TBL] [Abstract][Full Text] [Related]
24. Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women's Health Initiative.
Luo J; Sands M; Wactawski-Wende J; Song Y; Margolis KL
Am J Epidemiol; 2013 Jan; 177(1):42-9. PubMed ID: 23221728
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.
Shufelt C; Bairey Merz CN; Pettinger MB; Choi L; Chlebowski R; Crandall CJ; Liu S; Lane D; Prentice R; Manson JE;
Menopause; 2018 Sep; 25(9):985-991. PubMed ID: 29738414
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study.
Pressler M; Rosenberg CA; Derman BA; Greenland P; Khandekar J; Rodabough RJ; McTiernan A; Simon MS
Breast Cancer Res Treat; 2013 Jun; 139(3):821-31. PubMed ID: 23760856
[TBL] [Abstract][Full Text] [Related]
27. Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort.
Fournier A; Mesrine S; Dossus L; Boutron-Ruault MC; Clavel-Chapelon F; Chabbert-Buffet N
Breast Cancer Res Treat; 2014 Jun; 145(2):535-43. PubMed ID: 24781971
[TBL] [Abstract][Full Text] [Related]
28. Physical activity and breast cancer risk among pre- and postmenopausal women in the U.S. Radiologic Technologists cohort.
Howard RA; Leitzmann MF; Linet MS; Freedman DM
Cancer Causes Control; 2009 Apr; 20(3):323-33. PubMed ID: 18941914
[TBL] [Abstract][Full Text] [Related]
29. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).
Morimoto LM; White E; Chen Z; Chlebowski RT; Hays J; Kuller L; Lopez AM; Manson J; Margolis KL; Muti PC; Stefanick ML; McTiernan A
Cancer Causes Control; 2002 Oct; 13(8):741-51. PubMed ID: 12420953
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
Park NJ; Chang Y; Bender C; Conley Y; Chlebowski RT; van Londen GJ; Foraker R; Wassertheil-Smoller S; Stefanick ML; Kuller LH
PLoS One; 2017; 12(9):e0184174. PubMed ID: 28934233
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
[TBL] [Abstract][Full Text] [Related]
32. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
Grimes DA; Lobo RA
Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
[TBL] [Abstract][Full Text] [Related]
33. The Association of Predicted Resting Energy Expenditure with Risk of Breast Cancer among Postmenopausal Women in the Women's Health Initiative Cohort.
Arthur RS; Mossavar-Rahmani Y; Prentice RL; Shadyab AH; Luo J; Sattari M; Xue X; Kamensky V; Chen GC; Qi Q; Anderson GL; Wassertheil-Smoller S; Neuhouser ML; Rohan TE
Cancer Prev Res (Phila); 2022 Apr; 15(4):255-264. PubMed ID: 35012972
[TBL] [Abstract][Full Text] [Related]
34. The Combined Association of Modifiable Risk Factors with Breast Cancer Risk in the Women's Health Initiative.
Arthur R; Wassertheil-Smoller S; Manson JE; Luo J; Snetselaar L; Hastert T; Caan B; Qi L; Rohan T
Cancer Prev Res (Phila); 2018 Jun; 11(6):317-326. PubMed ID: 29483073
[TBL] [Abstract][Full Text] [Related]
35. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
Cold S; Cold F; Jensen MB; Cronin-Fenton D; Christiansen P; Ejlertsen B
J Natl Cancer Inst; 2022 Oct; 114(10):1347-1354. PubMed ID: 35854422
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.
Crandall CJ; Hovey KM; Andrews CA; Chlebowski RT; Stefanick ML; Lane DS; Shifren J; Chen C; Kaunitz AM; Cauley JA; Manson JE
Menopause; 2018 Jan; 25(1):11-20. PubMed ID: 28816933
[TBL] [Abstract][Full Text] [Related]
37. Investigating the association of lactation history and postmenopausal breast cancer risk in the Women's Health Initiative.
Stendell-Hollis NR; Thompson PA; Thomson CA; O'Sullivan MJ; Ray RM; Chlebowski RT
Nutr Cancer; 2013; 65(7):969-81. PubMed ID: 24127779
[TBL] [Abstract][Full Text] [Related]
38. Migraine history and breast cancer risk among postmenopausal women.
Li CI; Mathes RW; Bluhm EC; Caan B; Cavanagh MF; Chlebowski RT; Michael Y; O'Sullivan MJ; Stefanick ML; Prentice R
J Clin Oncol; 2010 Feb; 28(6):1005-10. PubMed ID: 20100960
[TBL] [Abstract][Full Text] [Related]
39. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L
Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137
[TBL] [Abstract][Full Text] [Related]
40. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
